Pierre Fabre SA and Puma Biotechnology, Inc. have broadened the geographic coverage of their license agreement...
Up To Date
Latest News
The European Commission and the European Investment Bank (EIB) have selected ECBF Management GmbH as...
French researchers have found MALT1 blockers not only to act on blood cancers but also to be effective as a...
Researchers have designed a limb girdle muscular dystrophy 2A gene therapy preventing cardiotoxicity of...
Having secured a €2.785m grant from the EU and €4.55m from a Series B round, MaxiVAX is going full steam...
Geneva-based GeNeuro SA announced a new clinical study of temelimab to treat patients with multiple sclerosis...